Suven Pharmaceuticals has informed that Kotak Mahindra Capital Company (Manager to the Open Offer) has submitted a copy of Letter of Offer for the attention of the public shareholders of Suven Pharmaceuticals (Target Company).
The above information is a part of company’s filings submitted to BSE.